Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome

Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated with increased mortality due to cardiovascular disease. Second-generation antipsychotics (SGAs) play an important role in facilitating MetS. Objective: The study aimed to assess weight changes and alte...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Psychiatry
Auteurs principaux: Kornetova, Elena G., Kornetov, Alexander N., Mednova, Irina A., Dubrovskaya, Viktoria V., Boiko, Anastasia S., Bokhan, Nikolay A., Loonen, Anton J. M., Ivanova, Svetlana A.
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2019
Sujets:
Psychiatry
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6838009/
https://ncbi.nlm.nih.gov/pubmed/31736812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2019.00803
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires